Markets:

Overview

News

Currencies

International

Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

437.15 +2.63 (+0.61%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9

...

68 69 Next >

4 No-Brainer Stocks to Buy Right Now ↗

May 09, 2025

Via The Motley Fool

Unpacking Q1 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks

May 08, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q1, starting with Vertex...

Via StockStory

Topics Artificial Intelligence

Top S&P500 movers in Wednesday's session ↗

May 07, 2025

Curious about the top performers within the S&P500 index one hour before the close of the markets on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive...

Via Chartmill

What's going on in today's session: S&P500 movers ↗

May 07, 2025

Stay informed about the performance of the S&P500 index in the middle of the day on Wednesday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

Earnings Scheduled For May 5, 2025 ↗

May 05, 2025

Via Benzinga

Why Vertex Pharmaceuticals Stock Is a Screaming Buy on the Dip ↗

May 07, 2025

Via The Motley Fool

Topics Earnings Intellectual Property Law Enforcement

Market Monitor May 7 ( Hims & Hers Health, Upwork UP - Palantir, Monderna DOWN) ↗

May 07, 2025

Markets slide on vaccine regulation fears, trade uncertainty, and cautious earnings despite strong tech and consumer stock moves.

Via Chartmill

1 S&P 500 Stock with Impressive Fundamentals and 2 to Ignore

May 07, 2025

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some...

Via StockStory

Topics Stocks

Why Did Vertex Pharmaceuticals Stock Fall On Tuesday? ↗

May 06, 2025

Vertex posted Q1 EPS and sales below estimates but raised its 2025 revenue outlook, driven by CF drug demand and new product launches in the U.S.

Via Benzinga

What's going on in today's session: S&P500 movers ↗

May 06, 2025

Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

Stocks Fall On Trade Concerns, Oil And Gold Rally: What's Driving Markets Tuesday? ↗

May 06, 2025

Wall Street edged lower by midday Tuesday as uncertainty surrounding trade policies lingered, with investors adopting a cautious approach ahead of Wednesday’s Federal Reserve meeting.

Via Benzinga

Topics Economy

Uncover the latest developments among S&P500 stocks in today's session. ↗

May 06, 2025

Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.

Via Chartmill

Why Vertex Pharmaceuticals Stock Is Sinking Today ↗

May 06, 2025

Via The Motley Fool

Which S&P500 stocks are gapping on Tuesday? ↗

May 06, 2025

Wondering which stocks are making significant price gaps? Explore the S&P500 index on Tuesday to find the gap up and gap down stocks in today's session.

Via Chartmill

Vertex Pharmaceuticals Topples 12% On A Series Of First-Quarter Setbacks ↗

May 06, 2025

The company paused a study of a cystic fibrosis treatment, right on the heels of a scrapped type 1 diabetes program.

Via Investor's Business Daily

Topics Government Intellectual Property

Nike To $70? Here Are 10 Top Analyst Forecasts For Tuesday ↗

May 06, 2025

Via Benzinga

Rising Costs Weigh on Vertex Q1 Earnings ↗

May 06, 2025

Via The Motley Fool

Topics Intellectual Property

Wondering what's happening in today's S&P500 pre-market session? ↗

May 06, 2025

Discover the top S&P500 movers in Tuesday's pre-market session and stay informed about market dynamics.

Via Chartmill

Ichor Holdings Posts Weak Earnings, Joins Fabrinet, Vertex Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

May 06, 2025

Via Benzinga

This Vertex Pharmaceuticals Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Tuesday ↗

May 06, 2025

Via Benzinga

Vertex Pharma Stock’s Retail Buzz Intensifies As 2025 Revenue View Lift Fails To Offset Q1 Miss ↗

May 05, 2025

The company’s Q1 revenue missed expectations, but the company raised its 2025 revenue guidance, reflecting optimism about growth drivers like cystic fibrosis treatments and its expanding pipeline.

Via Stocktwits

Topics World Trade

Monday's after hours session: top gainers and losers in the S&P500 index ↗

May 05, 2025

Let's have a look at what is happening on the US markets after the closing bell on Monday. Below you can find the top S&P500 gainers and losers in today's after hours session.

Via Chartmill

Vertex Pharmaceuticals Stock Falls On Q1 Earnings, Revenue Miss — Company Raises Low End Of FY25 Revenue Guidance ↗

May 05, 2025

Vertex Pharmaceuticals reports first-quarter financial results after the market close on Monday. Here's a look at the key highlights from the period.

Via Benzinga

Vertex Pharmaceuticals (NASDAQ:VRTX) Reports Sales Below Analyst Estimates In Q1 Earnings

May 05, 2025

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) missed Wall Street’s revenue expectations in Q1 CY2025 as sales rose 3% year on year to $2.77 billion. The company’s full-year revenue guidance of...

Via StockStory

Vertex Reports First Quarter 2025 Financial Results

May 05, 2025

From Vertex Pharmaceuticals Incorporated

Via Business Wire

Vertex Has Lost Some Sizzle Into Q1 Earnings - Can Alyftrek, Journavx Reignite The Momentum? ↗

May 05, 2025

Vertex Pharmaceuticals Inc (NASDAQ:VRTX) reports Q1 earnings with $4.32 EPS and $2.85B revenue. Stock up 25.48% in past year, charts show bullish trend.

Via Benzinga

Stocks Pause Gains As Treasury Yields Rise: What's Driving Markets Monday? ↗

May 05, 2025

Wall Street kicked off the week with a cautious tone, as major stock indices hovered near the flatline by midday in New York. Investors digested fresh signs of inflationary pressure in the services...

Via Benzinga

Vertex Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call ↗

May 05, 2025

Via Benzinga

Stock Market Selloff: 4 No-Brainer Stocks to Buy Right Now ↗

May 05, 2025

Now may be a smart time to buy small stakes in these fundamentally robust companies.

Via The Motley Fool

Topics Artificial Intelligence Economy

3 No-Brainer Stocks to Buy in May ↗

May 05, 2025

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

68 69 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Vertex Pharmaceuticals (NQ:VRTX)

All News about Vertex Pharmaceuticals

Starting at $3.75/week.

Subscribe Today